These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 36448893)

  • 1. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology.
    Thorel L; Perréard M; Florent R; Divoux J; Coffy S; Vincent A; Gaggioli C; Guasch G; Gidrol X; Weiswald LB; Poulain L
    Exp Mol Med; 2024 Jul; ():. PubMed ID: 38945959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biohybrid Hydrogels for Tumoroid Culture.
    Castellote-Borrell M; Merlina F; Rodríguez AR; Guasch J
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300118. PubMed ID: 37505458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles.
    Taha EA; Sogawa C; Okusha Y; Kawai H; Oo MW; Elseoudi A; Lu Y; Nagatsuka H; Kubota S; Satoh A; Okamoto K; Eguchi T
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
    Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
    Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Organoid Era Permits the Development of New Applications to Study Glioblastoma.
    Andreatta F; Beccaceci G; Fortuna N; Celotti M; De Felice D; Lorenzoni M; Foletto V; Genovesi S; Rubert J; Alaimo A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoids in Translational Oncology.
    Tatullo M; Marrelli B; Benincasa C; Aiello E; Makeeva I; Zavan B; Ballini A; De Vito D; Spagnuolo G
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32867142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques.
    Abd El-Salam MA; Troulis MJ; Pan CX; Rao RA
    Cancer Cytopathol; 2024 Feb; 132(2):96-102. PubMed ID: 37843532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of a lung cancer organoid (tumoroid) culture system.
    Yokota E; Iwai M; Yukawa T; Yoshida M; Naomoto Y; Haisa M; Monobe Y; Takigawa N; Guo M; Maeda Y; Fukazawa T; Yamatsuji T
    NPJ Precis Oncol; 2021 Apr; 5(1):29. PubMed ID: 33846488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.
    Granat LM; Kambhampati O; Klosek S; Niedzwecki B; Parsa K; Zhang D
    Animal Model Exp Med; 2019 Sep; 2(3):150-161. PubMed ID: 31773090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion Analysis.
    Liu YC; Ansaryan S; Tan J; Broguiere N; Lorenzo-Martín LF; Homicsko K; Coukos G; Lütolf MP; Altug H
    Adv Sci (Weinh); 2024 Jun; ():e2401539. PubMed ID: 38924371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor hyperthermia research progress and application prospect in tumoroids (Review).
    Mao W; Li W; Hu X
    Mol Clin Oncol; 2024 Apr; 20(4):31. PubMed ID: 38476334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards functional precision oncology with human organoids.
    Wang Z; Niu X; Cui C; Ouyang M; Li Q; Li Z; Liang L
    Lancet; 2023 Oct; 402(10412):1526-1527. PubMed ID: 37748492
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine.
    Sanchez-Fdez A; Sharma AK; Tiriac H; Sicklick JK
    Ann Surg Oncol; 2022 Nov; 29(12):7239-7241. PubMed ID: 35831519
    [No Abstract]   [Full Text] [Related]  

  • 14. Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.
    Viergever BJ; Raats DAE; Geurts V; Mullenders J; Jonges TN; van der Heijden MS; van Es JH; Kranenburg O; Meijer RP
    Br J Cancer; 2024 Feb; 130(3):369-379. PubMed ID: 38102228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making.
    Chitrangi S; Vaity P; Jamdar A; Bhatt S
    BMC Cancer; 2023 Aug; 23(1):768. PubMed ID: 37596562
    [No Abstract]   [Full Text] [Related]  

  • 16. [Patient-derived tumor organoids (or tumoroid), a growing preclinical model for oncology].
    Thorel L; Florent R; Perréard M; Vincent A; Poulain L; Weiswald LB
    Med Sci (Paris); 2022 Nov; 38(11):880-887. PubMed ID: 36448893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patient-derived tumor organoids (or tumoroid) as valuable precision medicine tools].
    Perréard M; Florent R; Thorel L; Vincent A; Weiswald LB; Poulain L
    Med Sci (Paris); 2022 Nov; 38(11):888-895. PubMed ID: 36448894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.
    Kalla J; Pfneissl J; Mair T; Tran L; Egger G
    Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38806997
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.